Showing results (381-390 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|October 30, 2003
Association between ABCB1 (multidrug resistance transporter) genotype and post-liver transplantation renal dysfunction in patients receiving calcineurin inhibitorsMary F Hebert, Amy L Dowling, Cynthia Gierwatowski, et al.Pharmacogenetics|October 1, 1995
Frequency of mutant CYP1A1, NAT2 and GSTM1 alleles in normal Indians and MalaysB Zhao, E J Lee, J Y Wong, et al.Pharmacogenetics|October 1, 1995
A multifamily study on the relationship between CYP2C19 genotype and s-mephenytoin oxidation phenotypeK Brøsen, S M de Morais, U A Meyer, et al.Pharmacogenetics|April 1, 1993
Catechol O-methyltransferase pharmacogenetics: photoaffinity labelling and western blot analysis of human liver samplesS Aksoy, J Klener, R M WeinshilboumPharmacogenetics|April 1, 1993
Tolbutamide hydroxylation in humans: lack of bimodality in 106 healthy subjectsM E Veronese, J O Miners, D L Rees, et al.Pharmacogenetics|February 1, 1997
Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomesB Rochat, M Amey, M Gillet, et al.Pharmacogenetics|February 1, 1997
Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherolL Le Marchand, A A Franke, L Custer, et al.Pharmacogenetics|February 1, 1997
Characterization of an unstable variant (BChE115D) of human butyrylcholinesteraseS L Primo-Parmo, H Lightstone, B N La DuPharmacogenetics|February 1, 1997
Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracilH Nakayama, T Kinouchi, K Kataoka, et al.Pharmacogenetics|February 1, 1997
Allelic and functional variability of cytochrome P4502C9C R Bhasker, J O Miners, S Coulter, et al.Pageof 83